Not all angiotensin-converting enzyme inhibitors are equal: focus on ramipril and perindopril.

Postgraduate medicine

Volumn 125, Issue 4, 2013, Pages 154-168

  Dinicolantonio, James J ^a   Lavie, Carl J ^b   O'Keefe, James H ^b  

^a Wegmans Pharmacy   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PERINDOPRIL; RAMIPRIL;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DRUG EFFECT; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; REVIEW;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; CORONARY DISEASE; HEART FAILURE; HUMANS; HYPERTENSION; MYOCARDIAL INFARCTION; PERINDOPRIL; RAMIPRIL;

EID: 84885897064     PISSN: None     EISSN: 19419260     Source Type: None    
DOI: 10.3810/pgm.2013.07.2687     Document Type: Review

References (0)